This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Objectives The clinical outcomes of transcatheter aorticvalve replacement (TAVR) in patients with aortic stenosis (AS) and concomitant active cancer remain insufficiently explored. Results Of the 2336 patients who underwent TAVR from October 2013 to July 2017, 89 patients (3.8%) had active cancer, whereas 2247 did not.
BACKGROUND:A high permanent pacemaker implantation (PPI) risk remains a concern of self-expandable transcatheter aorticvalve implantation, despite the continued improvements in implantation methodology. There were no group differences in 30-day all-cause mortality (1.4% versus 0%;P=0.608).CONCLUSIONS:Our
Objectives To explore the ethnic differences in patients undergoing aorticvalve (AV) intervention for severe aortic stenosis (AS) in Leicestershire, UK.
Analysis of 13,587 patients undergoing isolated tricuspid valve surgery from 2017 to 2023 revealed a 5.5% SAVR after TAVR Surgical aorticvalve replacement after prior TAVR is the fastest-growing cardiac surgery procedure in the U.S. More than 5,500 multi-valve procedures were performed in the U.S.
A 76-year-old woman with a history of double valve replacement (Aortic and mitral valves) for rheumatic heart disease, presented with acute dyspnea after a switch from Warfarin to LMWH before a planned bone marrow biopsy. Hence distal protection by an Aortic sentinel device or its equivalent (FilterWire EZ, Tri-guard) is a must.
Background Increase in left ventricular filling pressure (FP) and diastolic dysfunction are established consequences of progressive aortic stenosis (AS). However, the impact of elevated FP as detected by pretranscatheter aorticvalve replacement (TAVR) echocardiogram on long-term outcomes after TAVR remains unclear.
Background Patients undergoing transcatheter aorticvalve implantation (TAVI) often have multiple comorbidities, such as anaemia and chronic inflammatory disorders. We sought to investigate the association between preoperative and postoperative haematological parameters and clinical outcomes in TAVI patients at mid-term follow-up.
Cardiac Surgery after Transcatheter AorticValve Replacement: Trends and Outcomes The researchers set out to document trends and outcomes in cardiac surgery following transcatheter aorticvalve replacement (TAVR), a topic gaining importance as reports of subsequent cardiac operations and early TAVR explantations increase.
Background: Atrial fibrillation (AF) is common in patients undergoing transcatheter aorticvalve replacement (TAVR) and is associated with increased risk of bleeding and stroke. Conclusions: Concomitant WATCHMAN LAAO and TAVR is noninferior to TAVR with medical therapy in severe aortic stenosis patients with AF.
The miniature Elevate device is folded and delivered percutaneously through the femoral artery (8 Fr inner diameter, 10 Fr sheath), passing through the aorta and aorticvalve, before self-expanding in patients’ hearts where it controls blood flow (surpassing 5 L/min of mean flow, 8L/min peak). acquisition by J&J.
Objectives To describe the occurrence of significant pericardial effusion, and to investigate characteristics associated with pericardial effusion within three months following heart valve surgery. per year) and concomitant coronary artery bypass grafting versus isolated valve surgery (HR 0.58, 95% CI 0.35
The next morning the patient went for his routine echocardiogram, where the operator noticed a dilated aortic root at 5.47 cm with severe aortic insufficiency. The team was notified and they ordered a stat aortagram which showed type A aortic dissection from the aorticvalve to the iliacs. 15-9/6/2017 ).
Background Treatment of severe aortic stenosis with transcatheter aorticvalve implantation (TAVI) was introduced in 2002. The 13-year period was divided into period 1 (2008–2012), period 2 (2013–2017), and period 3 (2018–2021).
Objective A paucity of data exists on how transcatheter aorticvalve implantation (TAVI) practice has evolved in Ireland. This study sought to analyse temporal trends in patient demographics, procedural characteristics, and clinical outcomes at an Irish tertiary referral centre. mean Society of Thoracic Surgeons score 5.9±5.1).
It further reported that MHIF led the way as the first to provide this technology to a patient as part of an early research study in 2017 and completed the first-in-the-world enrollment in the pivotal trial in August 2019.
Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)
Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)
Background Transcatheter aorticvalve replacement (TAVR) is increasingly used for aorticvalve replacement instead of surgical aorticvalve replacement (sAVR). Methods Data were extracted from the Nationwide Readmissions Database from 2012 to 2017. Diabetes was present in 36.4% of sAVR patients.
Here is a simple research paper on echocardiography , yet comprehensive, that assessed aortic leaflet separation distance with mean aortic gradient and valve area in patients with aortic stenosis. Reference Jayaprakash K, Dilu V, George R.Maximal AorticValve Cusp Separation and Severity of Aortic Stenosis.J
Larger shunt volume means less blood exiting the left ventricle through the aorticvalve and lower cardiac output. The pressure gradient in this case was significant indicating that the defect is rather small. The larger the size of the defect the larger the shunt. Clinical correlation must always be sought before decision making.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content